1. Home
  2. RDY vs UNM Comparison

RDY vs UNM Comparison

Compare RDY & UNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • UNM
  • Stock Information
  • Founded
  • RDY 1984
  • UNM 1848
  • Country
  • RDY India
  • UNM United States
  • Employees
  • RDY N/A
  • UNM N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • UNM Accident &Health Insurance
  • Sector
  • RDY Health Care
  • UNM Finance
  • Exchange
  • RDY Nasdaq
  • UNM Nasdaq
  • Market Cap
  • RDY 12.1B
  • UNM 14.4B
  • IPO Year
  • RDY N/A
  • UNM 1986
  • Fundamental
  • Price
  • RDY $13.79
  • UNM $69.55
  • Analyst Decision
  • RDY Strong Buy
  • UNM Buy
  • Analyst Count
  • RDY 2
  • UNM 13
  • Target Price
  • RDY $16.95
  • UNM $91.62
  • AVG Volume (30 Days)
  • RDY 1.5M
  • UNM 1.7M
  • Earning Date
  • RDY 07-23-2025
  • UNM 07-29-2025
  • Dividend Yield
  • RDY 0.52%
  • UNM 2.65%
  • EPS Growth
  • RDY 2.20
  • UNM 24.02
  • EPS
  • RDY 0.79
  • UNM 8.42
  • Revenue
  • RDY $3,897,394,052.00
  • UNM $12,906,600,000.00
  • Revenue This Year
  • RDY $7.61
  • UNM $4.17
  • Revenue Next Year
  • RDY $1.89
  • UNM $3.85
  • P/E Ratio
  • RDY $17.40
  • UNM $8.24
  • Revenue Growth
  • RDY 15.86
  • UNM 1.86
  • 52 Week Low
  • RDY $12.26
  • UNM $52.65
  • 52 Week High
  • RDY $16.89
  • UNM $84.48
  • Technical
  • Relative Strength Index (RSI)
  • RDY 40.12
  • UNM 31.82
  • Support Level
  • RDY $13.32
  • UNM $68.28
  • Resistance Level
  • RDY $14.86
  • UNM $71.00
  • Average True Range (ATR)
  • RDY 0.23
  • UNM 1.63
  • MACD
  • RDY -0.05
  • UNM -0.79
  • Stochastic Oscillator
  • RDY 31.29
  • UNM 10.01

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About UNM Unum Group

Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum USA, Unum International, Closed Block, Colonial Life, and Corporate. The majority of the revenue is earned from the Unum USA segment. The firm markets its products through brokers.

Share on Social Networks: